Analysis of more than 2,100 men in the SPARTAN and TITAN trials found that those taking this drug with apalutamide and hormone therapy had higher 3-year survival rates
Go to Source
Author: News18
Go to Source
Author: News18
Hot this week
Free News - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Get important news delivered directly to your inbox and stay connected!